Product-By-Process Patents In Orange Book Should Claim Novel Products – FTC
FDA should ensure that product-by-process patents listed in the "Orange Book" claim only novel products, the Federal Trade Commission said in comments on FDA's proposed rule
FDA should ensure that product-by-process patents listed in the "Orange Book" claim only novel products, the Federal Trade Commission said in comments on FDA's proposed rule